Download Files:
Anti-CD22-NMS249
Products Details
Product Description
– Anti-CD22-NMS249 is an antibody-drug conjugate (ADC) that targets CD22, comprising the humanized anti-CD22 antibody Pinatuzumab, a cleavable linker (Mc-VC-PAB), and the effective payload of DNA topoisomerase II inhibitor PNU-159682. This compound is utilized in the study of non-Hodgkin lymphoma (NHL).
Web ID
– T9901A-233
Storage Temperature
– -20℃
Shipping
– Blue Ice
Molecular Formula
– C41H45F3N8O5S
Molecular Weight
– C41H45F3N8O5S
SMILES
– S=C1N(C(=O)C(C)(C)N1C2=CC(CC)=C(OCCN3C[C@@H](C)N(CC(NC4=CC(N[C@H]5C(=O)NC(=O)CC5)=CC=C4)=O)CC3)C=C2)C6=CC(C(F)(F)F)=C(C#N)C=C6
Pathway
– Antibody-drug Conjugate/ADC Related
Product type
– Inhibitory Antibodies
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
Related Products
Anti-SARS-CoV-2 Spike mAb (CR3022)
835 CAD – 1,389 CADPrice range: 835 CAD through 1,389 CAD
1000 in stock
1000 in stock
1000 in stock
1000 in stock